Citigroup’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-23,901
Closed -$146K 6280
2021
Q3
$146K Sell
23,901
-264,527
-92% -$1.65M ﹤0.01% 4262
2021
Q2
$2.37M Buy
288,428
+108,353
+60% +$921K ﹤0.01% 2535
2021
Q1
$1.61M Buy
180,075
+157,888
+712% +$1.81M ﹤0.01% 2634
2020
Q4
$256K Buy
22,187
+17,571
+381% +$204K ﹤0.01% 4800
2020
Q3
$48K Sell
4,616
-38,809
-89% -$476K ﹤0.01% 5630
2020
Q2
$571K Buy
43,425
+3,313
+8% +$34.4K ﹤0.01% 4120
2020
Q1
$316K Sell
40,112
-25,872
-39% -$390K ﹤0.01% 4307
2019
Q4
$1.37M Sell
65,984
-76,805
-54% -$1.3M ﹤0.01% 3418
2019
Q3
$1.96M Buy
142,789
+67,840
+91% +$805K ﹤0.01% 2887
2019
Q2
$922K Buy
74,949
+36,406
+94% +$420K ﹤0.01% 3728
2019
Q1
$480K Sell
38,543
-221,209
-85% -$2.96M ﹤0.01% 4220
2018
Q4
$2.94M Buy
259,752
+171,605
+195% +$2.69M 0.01% 2312
2018
Q3
$1.65M Buy
88,147
+22,251
+34% +$511K ﹤0.01% 2941
2018
Q2
$1.7M Sell
65,896
-12,215
-16% -$317K ﹤0.01% 2819
2018
Q1
$1.75M Sell
78,111
-49,396
-39% -$1.21M ﹤0.01% 2726
2017
Q4
$3.19M Buy
127,507
+92,185
+261% +$2.26M 0.01% 2240
2017
Q3
$854K Sell
35,322
-2,768
-7% -$65.1K ﹤0.01% 3548
2017
Q2
$770K Buy
38,090
+22,969
+152% +$478K ﹤0.01% 3577
2017
Q1
$407K Sell
15,121
-13,571
-47% -$277K ﹤0.01% 4047
2016
Q4
$546K Buy
28,692
+26,194
+1,049% +$501K ﹤0.01% 4283
2016
Q3
$49K Sell
2,498
-756
-23% -$12.8K ﹤0.01% 5678
2016
Q2
$48K Sell
3,254
-7,587
-70% -$95.4K ﹤0.01% 5600
2016
Q1
$100K Buy
10,841
+5,834
+117% +$70.7K ﹤0.01% 5658
2015
Q4
$97K Buy
5,007
+5,005
+250,250% +$86.9K ﹤0.01% 5398
2015
Q3
$0 Sell
2
-214
-99% -$5.02K ﹤0.01% 7885
2015
Q2
$5K Sell
216
-4,614
-96% -$93.1K ﹤0.01% 6795
2015
Q1
$109K Buy
4,830
+3,748
+346% +$86.8K ﹤0.01% 4972
2014
Q4
$22K Buy
1,082
+875
+423% +$15.9K ﹤0.01% 6172
2014
Q3
$4K Buy
207
+169
+445% +$2.45K ﹤0.01% 6680
2014
Q2
$1K Buy
38
+16
+73% +$218 ﹤0.01% 6995
2014
Q1
$0 Buy
+22
New +$380 ﹤0.01% 7274